MacroGenics | MGNX - Pre Tax Profit


MacroGenics reported $-36.77M in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
AbbVie USD 7.61B 2.04B Jun/2026
Amgen USD 2.08B 570M Mar/2026
AstraZeneca USD 4.81B 894M Jun/2026
Biogen USD 647.3M 269.6M Jun/2026
Bristol-Myers Squibb USD 4.99B 1.75B Jun/2026
Daiichi Sankyo JPY -6.52B 113.25B Mar/2026
Eli Lilly USD 8.85B 583.8M Mar/2026
Genmab DKK 295M 221M Jun/2026
Geron USD -3.64M 27.5M Mar/2026
Gilead Sciences USD -7.53B 10.11B Jun/2026
J&J USD 8.66B 839M Jun/2026
Karyopharm Therapeutics USD -22.39M 17.51M Mar/2026
MacroGenics USD -36.77M 21.84M Mar/2026
Merck USD -3.53B 6.95B Mar/2026
Pfizer USD -653M 5.84B Jun/2026
Puma Biotechnology USD 20.61M 24.76M Sep/2024
Regeneron Pharmaceuticals USD 1.53B 696.6M Jun/2026
Roche Holding CHF 11.17B 6.38B Jun/2026
Xencor USD -21.92M 106.72M Jun/2026